Status:
COMPLETED
Use of Concomitant Medications in HIV-1 Infected Patients in a Large Community Practice in Sydney, Australia
Lead Sponsor:
Holdsworth House Medical Practice
Collaborating Sponsors:
Gilead Sciences
Conditions:
HIV
Eligibility:
All Genders
18+ years
Brief Summary
For the majority of patients, management of HIV-1 infection involves effective and well tolerated antiretroviral therapy with simplified pill load and dosing, exemplified by the availability of single...
Eligibility Criteria
Inclusion
- Documented HIV-1 infection
- Attendance during the study period for at least 2 visits \>3 months and \<12 months apart with measured laboratory virological or immunological markers (either on-site or at a co-management site).
Exclusion
- Attendance by patient with HIV infection who does not have laboratory markers of HIV viral load or CD4 count
- Incomplete/inaccessible patient records
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
1104 Patients enrolled
Trial Details
Trial ID
NCT02295384
Start Date
November 1 2014
End Date
June 1 2016
Last Update
September 12 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Holdsworth House Medical Practice
Darlinghurst, New South Wales, Australia, 2010